サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/12/07 | 9,600 | 9,670 | 9,070 | 9,110 | -280 | -3% | 807,800 |
| 2018/12/06 | 9,360 | 9,440 | 8,790 | 9,390 | -40 | -0.4% | 1,268,800 |
| 2018/12/05 | 9,630 | 9,820 | 9,220 | 9,430 | -350 | -3.6% | 1,230,100 |
| 2018/12/04 | 9,480 | 9,880 | 9,280 | 9,780 | +300 | +3.2% | 1,447,000 |
| 2018/12/03 | 9,570 | 9,860 | 9,290 | 9,480 | +810 | +9.3% | 1,981,600 |
| 2018/11/30 | 8,680 | 8,720 | 8,370 | 8,670 | -90 | -1% | 1,228,700 |
| 2018/11/29 | 8,300 | 8,840 | 8,240 | 8,760 | +610 | +7.5% | 1,311,200 |
| 2018/11/28 | 8,250 | 8,290 | 8,000 | 8,150 | -50 | -0.6% | 806,900 |
| 2018/11/27 | 7,920 | 8,310 | 7,610 | 8,200 | +290 | +3.7% | 976,400 |
| 2018/11/26 | 8,150 | 8,590 | 7,820 | 7,910 | +10 | +0.1% | 1,975,300 |
| 2018/11/22 | 7,800 | 8,050 | 7,600 | 7,900 | +300 | +3.9% | 953,100 |
| 2018/11/21 | 7,340 | 7,820 | 7,290 | 7,600 | +60 | +0.8% | 791,200 |
| 2018/11/20 | 7,800 | 8,070 | 7,280 | 7,540 | -330 | -4.2% | 1,301,900 |
| 2018/11/19 | 7,300 | 8,080 | 7,220 | 7,870 | +690 | +9.6% | 1,759,300 |
| 2018/11/16 | 6,790 | 7,310 | 6,710 | 7,180 | +410 | +6.1% | 1,319,900 |
| 2018/11/15 | 6,430 | 6,780 | 6,280 | 6,770 | +250 | +3.8% | 613,800 |
| 2018/11/14 | 6,730 | 6,930 | 6,420 | 6,520 | +10 | +0.2% | 1,191,000 |
| 2018/11/13 | 6,130 | 6,650 | 6,000 | 6,510 | +130 | +2% | 1,538,100 |
| 2018/11/12 | 7,050 | 7,070 | 6,190 | 6,380 | -500 | -7.3% | 2,255,000 |
| 2018/11/09 | 6,850 | 7,200 | 6,720 | 6,880 | -270 | -3.8% | 2,177,600 |
| 2018/11/08 | 7,390 | 7,550 | 6,630 | 7,150 | +60 | +0.8% | 4,117,300 |
| 2018/11/07 | 5,910 | 7,090 | 5,870 | 7,090 | +1,000 | +16.4% | 5,037,200 |
| 2018/11/06 | 6,090 | 6,090 | 6,000 | 6,090 | +1,000 | +19.6% | 2,393,600 |
| 2018/11/05 | 5,090 | 5,090 | 5,090 | 5,090 | +705 | +16.1% | 72,100 |
| 2018/11/02 | 4,385 | 4,385 | 4,385 | 4,385 | +700 | +19% | 85,700 |
| 2018/11/01 | 3,640 | 3,760 | 3,610 | 3,685 | +5 | +0.1% | 451,800 |
| 2018/10/31 | 3,430 | 3,690 | 3,410 | 3,680 | +320 | +9.5% | 571,500 |
| 2018/10/30 | 3,140 | 3,400 | 3,115 | 3,360 | +175 | +5.5% | 671,700 |
| 2018/10/29 | 3,480 | 3,525 | 3,150 | 3,185 | -270 | -7.8% | 823,400 |
| 2018/10/26 | 3,610 | 3,645 | 3,385 | 3,455 | -55 | -1.6% | 573,400 |
| 2018/10/25 | 3,620 | 3,655 | 3,450 | 3,510 | -240 | -6.4% | 826,200 |
| 2018/10/24 | 3,905 | 3,935 | 3,700 | 3,750 | -95 | -2.5% | 536,500 |
| 2018/10/23 | 3,940 | 4,020 | 3,815 | 3,845 | -45 | -1.2% | 824,300 |
| 2018/10/22 | 3,850 | 3,970 | 3,800 | 3,890 | +100 | +2.6% | 704,800 |
| 2018/10/19 | 3,740 | 3,805 | 3,675 | 3,790 | +25 | +0.7% | 342,700 |
| 2018/10/18 | 3,715 | 3,845 | 3,715 | 3,765 | +50 | +1.3% | 533,000 |
| 2018/10/17 | 3,665 | 3,725 | 3,585 | 3,715 | +120 | +3.3% | 429,500 |
| 2018/10/16 | 3,695 | 3,725 | 3,565 | 3,595 | -75 | -2% | 390,300 |
| 2018/10/15 | 3,705 | 3,730 | 3,610 | 3,670 | -35 | -0.9% | 303,700 |
| 2018/10/12 | 3,535 | 3,725 | 3,510 | 3,705 | +165 | +4.7% | 460,800 |
| 2018/10/11 | 3,375 | 3,620 | 3,355 | 3,540 | -105 | -2.9% | 711,200 |
| 2018/10/10 | 3,690 | 3,720 | 3,595 | 3,645 | -45 | -1.2% | 425,000 |
| 2018/10/09 | 3,610 | 3,745 | 3,530 | 3,690 | +115 | +3.2% | 361,100 |
| 2018/10/05 | 3,665 | 3,725 | 3,540 | 3,575 | -160 | -4.3% | 697,700 |
| 2018/10/04 | 3,795 | 3,865 | 3,640 | 3,735 | -90 | -2.4% | 475,300 |
| 2018/10/03 | 3,655 | 3,855 | 3,640 | 3,825 | +125 | +3.4% | 619,600 |
| 2018/10/02 | 4,000 | 4,010 | 3,690 | 3,700 | -245 | -6.2% | 1,099,100 |
| 2018/10/01 | 3,950 | 4,040 | 3,890 | 3,945 | ±0 | ±0% | 586,100 |
| 2018/09/28 | 4,000 | 4,115 | 3,780 | 3,945 | -55 | -1.4% | 953,500 |
| 2018/09/27 | 3,865 | 4,135 | 3,845 | 4,000 | +190 | +5% | 1,393,400 |
1601～
1650
件表示中 / 2502件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 217,100円 | - | - | 0.00% | - | 100.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 379,000円 | -6.4% | -71.8% | 5.01% | 42.33倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 311,500円 | +21.7% | +999.9% | 0.00% | 13.05倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 293,400円 | +7.9% | -3.3% | 2.73% | 8.16倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 204,200円 | +3.1% | -6.5% | 2.35% | 9.47倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
